Table 1.
Short Course (<2 days) n = 64 | Long Course (>2 days) n = 85 | ||
---|---|---|---|
Characteristic | n (%) | n (%) | p |
Gender | 0.70 | ||
Male | 41 (64.1) | 57 (67.1) | |
Female | 23 (35.9) | 28 (32.9) | |
Tobacco use | 0.34 | ||
Never | 16 (25.0) | 14 (16.5) | |
Former | 28 (43.8) | 46 (54.1) | |
Current | 20 (31.3) | 25 (29.4) | |
Diabetes | 6 (9.4) | 17 (20.0) | 0.08 |
Disease site | 0.22 | ||
Oral cavity/larynx/pharynx | 57 (89.1) | 69 (81.2) | |
Craniofacial | 2 (3.1) | 10 (11.8) | |
Craniofacial and oral cavity | 3 (4.7) | 4 (4.7) | |
Scalp | 2 (3.1) | 2 (2.4) | |
Disease type | 0.06 | ||
Benign | 3 (4.7) | 13 (15.3) | |
Malignant | 61 (95.3) | 72 (84.7) | |
Disease stage (if cancer) | 0.45 | ||
I | 1 (1.6) | 3 (3.5) | |
II | 5 (7.8) | 6 (7.1) | |
III | 10 (15.6) | 6 (7.1) | |
IV | 32 (50.0) | 31 (36.5) | |
Recurrent | 11 (17.2) | 21 (24.7) | |
Unknown | 2 (3.1) | 5 (5.9) | |
History of chemotherapy | 10 (15.6) | 17 (20.0) | 0.49 |
History of radiation | 17 (26.6) | 33 (38.8) | 0.12 |
Year of surgery | 0.001 | ||
2009–2010 | 15 (23.4) | 34 (40.0) | |
2011–2012 | 23 (35.9) | 39 (45.9) | |
2013–2014 | 26 (40.6) | 12 (14.1) |
n (Mean [SD]) | n (Mean [SD]) | p | |
---|---|---|---|
Age at surgery (years) | 64 (59.9 [14.2]) | 85 (59.0 [15.1]) | 0.69 |
Body mass index (kg/m2) | 64 (26.2 [6.1]) | 85 (26.6 [6.6]) | 0.70 |
Pre-operative hemoglobin | 55 (13.3 [1.9]) | 75 (12.9 [1.8]) | 0.26 |
SD = standard deviation.